Podjanee Jittamala

420/6 Rajvithi Road
Ratchathewi, 10400, Thailand

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 60 publications

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

Baloxavir marboxil, favipiravir, or oseltamivir in patients with non-severe symptomatic seasonal influenza (AD ASTRA): a phase 2, open-label, adaptive, randomised controlled trial.

Journal: The Lancet. Infectious diseases

Published: March 05, 2026

A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality.

A dynamic pharmacometric framework defining the relationship between ivermectin exposure and mosquito lethality.

Journal: Scientific reports

Published: December 11, 2025

Lethal effects of ivermectin structures on malaria vectors and in silico analysis of interactions with their glutamate-gated chloride ion channels.

Lethal effects of ivermectin structures on malaria vectors and in silico analysis of interactions with their glutamate-gated chloride ion channels.

Journal: Scientific reports

Published: August 25, 2025

Tafenoquine lactation pharmacokinetics: a pilot study.

Tafenoquine lactation pharmacokinetics: a pilot study.

Journal: Malaria journal

Published: August 06, 2025

Accurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019.

Accurate Measurement of Viral Clearance in Early-Phase Antiviral Studies in Coronavirus Disease 2019.

Journal: The Journal of infectious diseases

Published: June 22, 2025

Optimizing endectocide and ectocide compound evaluation in Anopheles malaria vectors.

Optimizing endectocide and ectocide compound evaluation in Anopheles malaria vectors.

Journal: Parasites & vectors

Published: May 27, 2025

Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.

Antiviral efficacy of oral ensitrelvir versus oral ritonavir-boosted nirmatrelvir in COVID-19 (PLATCOV): an open-label, phase 2, randomised, controlled, adaptive trial.

Journal: The Lancet. Infectious diseases

Published: April 02, 2025

Assessing monoclonal antibodies for respiratory virus infections.

Assessing monoclonal antibodies for respiratory virus infections.

Journal: Lancet (London, England)

Published: March 29, 2025

Characterizing viral clearance kinetics in acute influenza.

Characterizing viral clearance kinetics in acute influenza.

Journal: Philosophical transactions of the Royal Society of London. Series B, Biological sciences

Published: March 07, 2025

Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.

Within-host modeling of primaquine-induced hemolysis in hemizygote glucose-6-phosphate dehydrogenase deficient healthy volunteers.

Journal: Antimicrobial agents and chemotherapy

Published: February 24, 2025

Evaluation of the Wondfo G6PD/Hb Test for glucose-6-phosphate dehydrogenase deficiency: preliminary performance, matrix equivalence, and usability.

Evaluation of the Wondfo G6PD/Hb Test for glucose-6-phosphate dehydrogenase deficiency: preliminary performance, matrix equivalence, and usability.

Journal: Malaria journal

Published: December 12, 2024

Author Correction: Ivermectin metabolites reduce Anopheles survival.

Author Correction: Ivermectin metabolites reduce Anopheles survival.

Journal: Scientific reports

Published: October 25, 2024

Showing 1-12 of 60

Last Updated: 09/26/2026